コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 a mechanism responsible for postspaceflight orthostatic intolerance.
2 chanism underlying individual variability in orthostatic intolerance.
3 iciency is linked to tachycardia in familial orthostatic intolerance.
4 changes that might contribute to postflight orthostatic intolerance.
5 that may contribute to, rather than offset, orthostatic intolerance.
6 ts in the treatment of patients with chronic orthostatic intolerance.
7 povolemia alone, potentially contributing to orthostatic intolerance.
8 ributes to the pathophysiologic mechanism of orthostatic intolerance.
9 underlie hyperadrenergic states that lead to orthostatic intolerance.
10 an norepinephrine transporter contributes to orthostatic intolerance.
11 Women are more susceptible to orthostatic intolerance.
12 y are likely responsible for the symptoms of orthostatic intolerance across the menstrual cycle in wo
13 are probably responsible for the symptoms of orthostatic intolerance across the menstrual cycle in wo
17 Starling relationship, which contributes to orthostatic intolerance by causing an excessive reductio
18 rdiovascular adaptation to bed rest leads to orthostatic intolerance, characterized by an excessive f
21 s during head-up tilt (HUT) in patients with orthostatic intolerance during daily life, and to identi
23 by echocardiogram, weight loss > 10 pounds, orthostatic intolerance, fatigue) in combination were hi
26 ion between the chronic fatigue syndrome and orthostatic intolerance; however, treatment with the sal
34 uced red blood cell masses, hypovolaemia and orthostatic intolerance, marked by greater cardio-accele
36 ia syndrome (POTS) induces disabling chronic orthostatic intolerance notable for an excessive increas
37 repeated neurocardiogenic presyncope (NCS), orthostatic intolerance occurs without persistent sympat
38 ed by tilt-table testing on 15 subjects with orthostatic intolerance (OI) and UARS, five normotensive
43 (P< .001), primarily due to elevation of the orthostatic intolerance, secretomotor, upper gastrointes
45 ia syndrome (POTS) induces disabling chronic orthostatic intolerance with an excessive increase in he
46 re commonly used in the treatment of chronic orthostatic intolerance with postural tachycardia syndro
47 m onset (hazard ratio 1.67, P < 0.003); (iv) orthostatic intolerance within 1 year of symptom onset (
48 e hypothesized that patients with idiopathic orthostatic intolerance would have impaired cardiac vaga
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。